PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Symptom | |chronic infection |
| Sentences | 129 |
| PubMedID- 24175062 | chronic infection with hepatitis c virus (hcv) is treated with a combined therapy of peginterferon-α-2a (pegifn-α-2a) or pegifn-α-2b and ribavirin. |
| PubMedID- 22534629 | Background: chronic infection with hepatitis c virus (hcv) is associated with failures of t-cell-mediated immune clearance and with abnormal b-cell growth and activation. |
| PubMedID- 20929104 | Cirrhosis due to chronic infection with hepatitis c virus remains by far the most common reason for liver transplantation in north america. |
| PubMedID- 26357633 | chronic infection with hepatitis c virus (hcv) carries a significant global health burden in both children and adults, with approximately 3% of the world's population infected. |
| PubMedID- 24156952 | In asymptomatic naive patients, cart is recommended if the cd4(+) lymphocyte count is <500cells/mul; if the cd4(+) lymphocyte count is >500cells/mul, cart can be delayed, although it may be considered in patients with liver cirrhosis, chronic infection due to hepatitis c virus, high cardiovascular risk, plasma viral load (pvl) >10(5)copies/ml, cd4(+) lymphocyte percentage <14%, cognitive impairment, and age >55 years. |
| PubMedID- 22648263 | Obermayer-straub and manns emphasized that chronic infections with hepatitis c virus (hcv) are associated with various autoimmune manifestations, including mixed cryoglobulinemia, membranoproliferative glomerulonephritis, autoimmune thyroid diseases, sporadic porphyria, cutanea tarda and b-cell lymphoma. |
| PubMedID- 26075599 | chronic infection with hepatitis c virus (hcv) is known as the major agent of chronic liver disease, hepatic cirrhosis, and hepatocellular carcinoma. |
| PubMedID- 23840511 | chronic infection with hepatitis c virus (hcv) is characterized by a broad spectrum of clinical manifestations that can culminate in decompensated cirrhosis. |
| PubMedID- 22869395 | Background and aim: hepatocellular carcinoma (hcc) is the most frequent form of primary liver cancer and chronic infection with hepatitis c virus is one of the main risk factors for hcc. |
| PubMedID- 20173735 | chronic infection with the hepatitis c virus (hcv) affects 170 million people worldwide and is an important cause of liver-related morbidity and mortality. |
| PubMedID- 23650587 | chronic infection with hepatitis c virus (hcv) is a global health problem affecting a significant proportion of world’s population. |
| PubMedID- PMC3882569 | chronic infection with hepatitis c virus (hcv) induces a chronic stimulation of b lymphocytes and, in some cases, this stimulation can lead to chronic lymphoid disorders like non-hodgkin lymphoma. |
| PubMedID- 21994696 | chronic infection with hepatitis c virus (hcv) is associated with significant liver disease and is therefore an important public health problem. |
| PubMedID- 26429337 | chronic infection with hepatitis c virus (chc) is a large public health problem, impacting an estimated three million people in the united states . |
| PubMedID- 23735335 | chronic infections with the hepatitis c virus (hcv) are a major global health issue. |
| PubMedID- 23226039 | chronic infection with hepatitis c virus (hcv) is a major public health problem, with perhaps 180 million people infected worldwide. |
| PubMedID- 20332260 | Background: chronic infection with hepatitis c virus (hcv) confers increased risk for chronic renal disease, and numerous reports suggest an association with renal cell carcinoma (rcc), a cancer with rapidly rising global incidence. |
| PubMedID- 21645344 | In this article we discuss several liver conditions which are directly affected by overweight and obese status, including non-alcoholic fatty liver disease, chronic infection with hepatitis c virus and post-liver transplant status. |
| PubMedID- 25013557 | chronic infection with hepatitis c virus (hcv) continues to be the most common indication for orthotopic liver transplantation (olt) in the united states and western europe. |
| PubMedID- 21326840 | chronic infection with hepatitis c virus is estimated to affect almost 4 million people in the usa, 5 million in europe, and 170 million worldwide 1. |
| PubMedID- 26186636 | chronic infection with the hepatitis c virus (hcv) is a cause of cirrhosis and hepatocellular carcinoma worldwide. |
| PubMedID- 22894766 | chronic infection with hepatitis c virus (hcv) is the predominant aetiology for the development of hepatocellular carcinoma (hcc) worldwide . |
| PubMedID- 19773667 | Objectives: although chronic infection with the hepatitis c virus (hcv) may lead to the development of cirrhosis and its complications, little data are available on progression to the decompensated stage in a hetereogeneous population. |
| PubMedID- 23577090 | Other well-established risk factors for hcc include chronic infection with hepatitis c virus (hcv), exposure to aflatoxin b1, male gender, drinking, smoking, non-alcoholic fatty liver disease and diabetes , , 7. |
| PubMedID- 22263340 | chronic infection with hepatitis c virus is a "silent epidemic", affecting 170 million people worldwide. |
| PubMedID- 19902246 | chronic infection with the hepatitis c virus (hcv) represents one of the major causes for end-stage liver disease worldwide. |
| PubMedID- 22491449 | The mechanisms of induction of liver injury during chronic infection with hepatitis c virus (hcv) are not well understood. |
| PubMedID- 21637766 | chronic infection with hepatitis c virus (hcv) has been estimated to affect 3.2 million persons in the united states and 130 million worldwide and is a leading cause of liver failure and the need for liver transplant . |
| PubMedID- 25579804 | Continuous hepatic inflammation as a result of chronic infection with the hepatitis c virus may lead to the development of fibrosis and eventually cirrhosis. |